Sonoma Pharmaceuticals, Inc. — All Filings
947 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
25-NSE
3
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
REGDEX
REGDEX/A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001683168-24-006556 | Sep 20, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-006053 | Aug 28, 2024 | Aug 23, 2024 |
| 8-K | FORM 8-K | 0001683168-24-005980 | Aug 23, 2024 | Aug 22, 2024 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-24-005978 | Aug 23, 2024 | — |
| 8-K | CURRENT REPORT | 0001683168-24-005938 | Aug 21, 2024 | Aug 19, 2024 |
| DEFA14A | FORM DEFA 14A | 0001683168-24-005723 | Aug 15, 2024 | — |
| DEFA14A | FORM DEFA 14A | 0001683168-24-005721 | Aug 15, 2024 | — |
| 10-Q | FORM 10-Q FOR JUNE 2024 | 0001683168-24-005371 | Aug 8, 2024 | Jun 30, 2024 |
| DEFA14A | FORM DEFA 14A | 0001683168-24-005018 | Jul 24, 2024 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-24-004552 | Jul 1, 2024 | Aug 14, 2024 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-24-004505 | Jun 27, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-004506 | Jun 27, 2024 | — |
| 4 | — | 0001683168-24-004424 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | — | 0001683168-24-004425 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | — | 0001683168-24-004423 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | — | 0001683168-24-004426 | Jun 21, 2024 | Jun 20, 2024 |
| PRE 14A | PRE 14A | 0001683168-24-004420 | Jun 21, 2024 | Aug 14, 2024 |
| S-8 | S-8 | 0001683168-24-004277 | Jun 17, 2024 | — |
| 10-K | FORM 10-K FOR 3/31/24 | 0001683168-24-004275 | Jun 17, 2024 | Mar 31, 2024 |
| 8-K | FORM 8-K | 0001683168-24-002224 | Apr 9, 2024 | — |
| 8-K | CURRENT REPORT | 0001683168-24-002051 | Apr 2, 2024 | — |
| 8-K | CURRENT REPORT | 0001683168-24-001635 | Mar 22, 2024 | Mar 21, 2024 |
| 8-K | CURRENT REPORT | 0001683168-24-001399 | Mar 8, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001683168-24-001397 | Mar 8, 2024 | — |
| 10-Q | FORM 10-Q FOR DEC 2023 | 0001683168-24-000781 | Feb 8, 2024 | Dec 31, 2023 |
| 8-K | CURRENT REPORT | 0001683168-24-000168 | Jan 10, 2024 | — |
| 8-K | CURRENT REPORT | 0001683168-24-000150 | Jan 9, 2024 | Jan 5, 2024 |
| 4 | — | 0001683168-23-009158 | Dec 29, 2023 | — |
| 4 | — | 0001683168-23-009154 | Dec 29, 2023 | — |
| 4 | — | 0001683168-23-009156 | Dec 29, 2023 | — |
| 8-K | FORM 8-K | 0001683168-23-009150 | Dec 29, 2023 | — |
| 4 | — | 0001683168-23-009152 | Dec 29, 2023 | — |
| 8-K | CURRENT REPORT | 0001683168-23-008898 | Dec 18, 2023 | Dec 15, 2023 |
| 424B3 | 424B3 | 0001683168-23-008892 | Dec 15, 2023 | — |
| 424B5 | FORM 424B5 | 0001683168-23-008423 | Nov 22, 2023 | — |
| EFFECT | — | 9999999995-23-003391 | Nov 20, 2023 | — |
| CORRESP | — | 0001683168-23-008241 | Nov 17, 2023 | — |
| 10-Q | QUARTERLY REPORT | 0001683168-23-007982 | Nov 13, 2023 | Sep 30, 2023 |
| UPLOAD | — | 0000000000-23-012168 | Nov 7, 2023 | — |
| S-3 | FORM S-3 | 0001683168-23-007624 | Nov 3, 2023 | — |
| 424B4 | FORM 424(B)(4) | 0001683168-23-007475 | Oct 30, 2023 | — |
| EFFECT | — | 9999999995-23-003093 | Oct 26, 2023 | — |
| CORRESP | — | 0001683168-23-007352 | Oct 24, 2023 | — |
| CORRESP | — | 0001683168-23-007353 | Oct 24, 2023 | — |
| CORRESP | — | 0001683168-23-007169 | Oct 13, 2023 | — |
| S-1/A | AMENDMENT TO FORM S-1 | 0001683168-23-007167 | Oct 13, 2023 | — |
| 8-K | CURRENT REPORT | 0001683168-23-007044 | Oct 11, 2023 | — |
| 8-K/A | CURRENT REPORT | 0001683168-23-007057 | Oct 11, 2023 | — |
| 8-K | FORM 8-K | 0001683168-23-006809 | Sep 28, 2023 | Sep 22, 2023 |
| UPLOAD | — | 0000000000-23-010681 | Sep 27, 2023 | — |